.
.
Voir ces articles:
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
Leukemia Patients Taking Gleevec Achieve ‘Normal’ Death Rate
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
.
.